Article Information
PubMed
Print ISSN
Online ISSN
History
- Received November 16, 2014
- Accepted January 9, 2015
- Published online February 20, 2015.
Article Versions
- Earlier version (January 13, 2015 - 08:06).
- Earlier version (January 16, 2015 - 05:12).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Caroline A. Lee1,
- Meeghan A. O’Connor,
- Tasha K. Ritchie,
- Aleksandra Galetin,
- Jack A. Cook,
- Isabelle Ragueneau-Majlessi,
- Harma Ellens,
- Bo Feng,
- Mitchell E. Taub,
- Mary F. Paine,
- Joseph W. Polli,
- Joseph A. Ware, and
- Maciej J. Zamek-Gliszczynski
- Drug Metabolism and Pharmacokinetics, QPS LLC, Research Triangle Park, North Carolina (C.A.L.); Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut (M.A.O., M.E.T.); Centre for Applied Pharmacokinetic Research, Manchester Pharmacy School, The University of Manchester, Manchester, United Kingdom (A.G.); Pharmacokinetics and Drug Metabolism (B.F.) and Clinical Pharmacology, Global Innovative Pharma Business (J.A.C.), Pfizer Inc., Groton, Connecticut; School of Pharmacy, University of Washington, Seattle, Washington (I.R.-M., T.K.R.); Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina (M.J.Z.-G., J.W.P.) and King of Prussia, Pennsylvania (H.E.); College of Pharmacy, Washington State University, Spokane, Washington (M.F.P.); and Clinical Pharmacology, Genentech, South San Francisco, California (J.A.W.)
- Address correspondence to:
Dr. Maciej J. Zamek-Gliszczynski, GlaxoSmithKline, Drug Metabolism and Pharmacokinetics, 5 Moore Drive, P.O. Box 13398, Research Triangle Park, NC 27709-3398. E-mail: maciej.x.zamek-gliszczynski{at}gsk.com
Statistics from Altmetric.com
Article usage
In this issue
BCRP Clinical DDI Study Design Recommendations
Jump to section
- Article
- Abstract
- Introduction
- Clinical Relevance of BCRP Polymorphisms
- Potential Clinical BCRP Probe Substrates
- Clinical Evidence-Based Recommendations for BCRP Substrate Selection
- Potential Clinical BCRP Inhibitors
- Clinical Evidence–Based Recommendations for BCRP Inhibitor Selection
- Recommendations for Clinical BCRP Drug Interaction Study Design
- Conclusions
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
- PDF + SI
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement